REDCARE PHARMACY : Warburg Research remains Neutral -April 05, 2024 at 05:16 am EDT : vimarsana.com

In his latest research note, analyst Michael Heider confirms his recommendation. The broker Warburg Research is keeping its Neutral rating. The target price continues to be set at EUR 138.

Related Keywords

Michael Heider , Warburg Research , Markets ,